Global Transdermal Drug Delivery Market 2014-2018

世界の経皮薬物送達システム市場(2014-2018)

◆タイトル:Global Transdermal Drug Delivery Market 2014-2018
◆商品コード:IRTNTR3714
◆調査・発行会社:Technavio (Infiniti Research Ltd.)
◆発行日:2014年6月30日
◆ページ数:76
◆資料形式:PDF / 英語
◆納品方法:Eメール
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥282,500見積依頼/購入/質問フォーム
Five UserUSD2,800 ⇒換算¥316,400見積依頼/購入/質問フォーム
Enterprise License(社内共有可)USD3,500 ⇒換算¥395,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、資料に記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はTechnavio (Infiniti Research Ltd.)の日本における正規販売代理店です。

【資料の概要】

本調査レポートでは、"世界の経皮薬物送達システム市場(2014-2018)"について調査・分析し、エグゼクティブサマリー、市場概観、市場規模及び予測、製品別分析、用途別分析、主要地域別分析、市場シェア、購買基準、市場成長要因、市場の課題、市場動向、競争状況、主要企業(ベンダー)分析等の情報をお届けいたします。

About Transdermal Drug Delivery
Transdermal drug delivery is a large and growing vertical market of the Pharmaceutical industry. Transdermal drug delivery is defined as a system that utilizes skin as a site for continuous drug administration into the systemic circulation. Several methods of transdermal drug delivery include plasters, various ointments and, most commonly, patches. Transdermal drug administration has several advantages. First, the method of delivery is non-invasive, which is much less traumatic to the patient as compared to other forms of drug delivery. Also, it can be effective in assuring that a patient receives a full dosage of a drug and helps in increasing the compliance rate. However, there are difficulties associated with administering medication through the skin. The natural function of the skin is to act as a protective barrier, so it is often the case that drugs are not chemically suitable to penetrating the skin.
TechNavio’s analysts forecast the Global Transdermal Drug Delivery market will grow at a CAGR of 9.92 percent over the period 2014-2018.
Covered in this Report
This report covers the present scenario and the growth prospects of the Global Transdermal Drug Delivery market for the period 2013–2018. To calculate the market size, the report considers the revenue generated from the sales of various drugs administered transdermally and proprietary transdermal technologies available in the market. The Global Transdermal Drug Delivery market can be divided into five segments: Smoking Cessation, Pain Management, Hormone Therapy, Cardiovascular Indications, and Others.
TechNavio’s report, the Global Transdermal Drug Delivery Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Transdermal Drug Delivery market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Key Regions
• Americas
• EMEA
• APAC
Key Vendors
• ANI Pharmaceuticals Inc.
• Antares Pharma Inc.
• Bayer AG
• Janssen Pharmaceuticals Inc.
• Novartis AG

Other Prominent Vendors

• 3M Pharmaceuticals Co.
• Durect Corp.
• Iontera Inc.
• Isis Biopolymer Inc.
• LTS Lohmann Therapie-Systeme AG
• Mylan Laboratories Inc.
• Nitto Denko Corp.
• Pantec Biosolutions AG

• Phosphagenics Ltd.
• Tesa Labtec GmbH
• Teva Pharmaceutical Industries Ltd.

Key Market Driver
• Increase in Number of Transdermal Drug Delivery Products
• For a full, detailed list, view our report
Key Market Challenge
• Availability of Alternatives
• For a full, detailed list, view our report
Key Market Trend
• Increase in R&D Activities
• For a full, detailed list, view our report
Key Questions Answered in this Report
• What will the market size be in 2018 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

【資料の目次】

01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Introduction
06. Market Landscape
06.1 Market Overview
06.2 Market Size and Forecast
06.3 Five Forces Analysis
07. Competitive Assessment of Transdermal Drugs Delivery Market
08. Optimisation of Transdermal Drug Delivery
09. Market Segmentation by Application
10. Geographical Segmentation
11. Buying Criteria
12. Market Growth Drivers
13. Drivers and their Impact
14. Market Challenges
15. Impact of Drivers and Challenges
16. Market Trends
17. Trends and their Impact
18. Vendor Landscape
18.1 Competitive Scenario
18.1.1 Key News
18.1.2 Mergers and Acquisitions
18.2 Market Share Analysis 2013
18.3 Other Prominent Vendors
19. Key Vendor Analysis
19.1 ANI Pharmaceuticals Inc.
19.1.1 Key Facts
19.1.2 Business Overview
19.1.3 Business Strategy
19.1.4 Business Segmentation
19.1.5 Business Segmentation by Revenue 2013
19.1.6 Business Segmentation by Revenue 2012 and 2013
19.1.7 Key Developments
19.1.8 SWOT Analysis
19.1.9 Strengths
19.1.10 Weaknesses
19.1.11 Opportunities
19.1.12 Threats
19.2 Antares Pharma Inc.
19.2.1 Key Facts
19.2.2 Business Overview
19.2.3 Business Segmentation
19.2.4 Business Strategy
19.2.5 Segmentation by Products
19.2.6 Key Information
19.2.7 SWOT Analysis
19.2.8 Strengths
19.2.9 Weaknesses
19.2.10 Opportunities
19.2.11 Threats
19.3 Bayer AG
19.3.1 Key Facts
19.3.2 Business Overview
19.3.3 Business Segmentation
19.3.4 Business Strategy
19.3.5 Sales Segmentation by Business
19.3.6 Sales by Geographical Segmentation
19.3.7 Key Information
19.3.8 SWOT Analysis
19.3.9 Strengths
19.3.10 Weaknesses
19.3.11 Opportunities
19.3.12 Threats
19.4 Janssen Pharmaceuticals Inc.
19.4.1 Key Facts
19.4.2 Business Overview
19.4.3 Business Segmentation
19.4.4 Business Strategy
19.4.5 Key Developments
19.4.6 SWOT Analysis
19.4.7 Strengths
19.4.8 Weaknesses
19.4.9 Opportunities
19.4.10 Threats
19.5 Novartis AG
19.5.1 Key Facts
19.5.2 Business Overview
19.5.3 Business Segmentation by Revenue 2013
19.5.4 Business Segmentation by Revenue 2012 and 2013
19.5.5 Sales by Geography
19.5.6 Business Strategy
19.5.7 Key Developments
19.5.8 SWOT Analysis
19.5.9 Strengths
19.5.10 Weaknesses
19.5.11 Opportunities
19.5.12 Threats
20. Other Reports in this Series

List of Exhibits
Exhibit 1: Market Research Methodology
Exhibit 2: Global Transdermal Drug Delivery Market 2013-2018 (US$ billion)
Exhibit 3: Global Transdermal Drug Delivery Market by Application
Exhibit 4: Global Transdermal Drug Delivery Market Segmentation 2013
Exhibit 5: Global Transdermal Drug Delivery Market by Geographical Segmentation
Exhibit 6: ANI Pharmaceuticals Inc.: Business Segmentation 2013
Exhibit 7: ANI Pharmaceuticals Inc.: Business Segmentation by Revenue 2013
Exhibit 8: Business Segmentation by Revenue 2012 and 2013 (US$ million)
Exhibit 9: Business Segmentation of Anatres Pharma, Inc. (2013)
Exhibit 10: Segmentation of Pipeline Products of Antares Pharma Inc. (2013)
Exhibit 11: Segmentation of Marketed Products of Antares Pharma Inc. (2013)
Exhibit 12: Business Segmentation of Bayer AG 2013
Exhibit 13: Sales Comparison of Bayer AG by Business Segment 2012 and 2013 (US$ million)
Exhibit 14: Sales Segmentation of Bayer AG by Geography 2013
Exhibit 15: Janssen Pharmaceuticals Inc.: Product Segmentation 2013
Exhibit 16: Novartis AG: Business Segmentation by Revenue 2013
Exhibit 17: Novartis AG: Business Segmentation by Revenue 2012 and 2013 (US$ million)
Exhibit 18: Novartis AG: Sales by Geography 2013



【掲載企業】

ANI Pharmaceuticals Inc., Antares Pharma Inc., Bayer AG , Janssen Pharmaceuticals Inc., Novartis AG, 3M Pharmaceuticals Co., Durect Corp., Iontera Inc., Isis Biopolymer Inc., LTS Lohmann Therapie-Systeme AG, Mylan Laboratories Inc., Nitto Denko Corp., Pantec Biosolutions AG , Phosphagenics Ltd., Tesa Labtec GmbH , Teva Pharmaceutical Industries Ltd.

【資料のキーワード】

経皮、薬物送達システム、ドラッグデリバリーシステム

【調査方法】

一次資料による調査(業界専門家、ベンダー、代理店、顧客等を対象にしたデプスインタビュー調査など)及び二次資料による調査(Technavio独自のプラットフォーム、産業書籍、企業報告書、ニュース記事、アナリストレポート、貿易協会、政府機関発行データなど)

★調査レポート[世界の経皮薬物送達システム市場(2014-2018)] (Global Transdermal Drug Delivery Market 2014-2018 / IRTNTR3714)販売に関する免責事項
[世界の経皮薬物送達システム市場(2014-2018)] (Global Transdermal Drug Delivery Market 2014-2018 / IRTNTR3714)についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆